Chemotherapy related tests
If you’re a woman with early-stage, hormone-receptor-positive breast cancer, the Prosigna test can help you and your clinician identify the best treatment options for you, particularly around the length of time it’s beneficial to have hormonal therapy.
It’s all about analysing your risk of distant recurrence (cancer coming back in a part of the body away from the breast) and applies if you are a postmenopausal woman within 10 years of diagnosis and with up to three positive lymph nodes after five years of hormonal therapy treatment.
If the test shows you to be low risk, it may be that hormone therapy is the only treatment you will need.
Advice, guidance and results...
Our service offers a full explanation of the results together with advice and guidance about ongoing management and surveillance, depending on the outcome of the result.
Order a test
Please call / email:
+44 (0) 207 293 0317
+44 (0) 7722 275780